Title:
HYALURONIC ACID DERIVATIVE DRUG COMPOSITION AND DRUG COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2024/019118
Kind Code:
A1
Abstract:
This hyaluronic acid derivative drug composition contains an active ingredient that is suspended in an aqueous carrier containing a hyaluronic acid derivative. The active ingredient is in the form of fine particles having a molecular weight of 100-8000 g/mol. The fine particles are preferably micro-particles or nano-particles.
Inventors:
NAKAI TAKASHI (JP)
YABUUCHI KOHEI (JP)
YABUUCHI KOHEI (JP)
Application Number:
PCT/JP2023/026609
Publication Date:
January 25, 2024
Filing Date:
July 20, 2023
Export Citation:
Assignee:
ASAHI CHEMICAL IND (JP)
International Classes:
A61K47/36; A61K9/10; A61K38/12; A61K38/13; C08B37/08
Domestic Patent References:
| WO2019098393A1 | 2019-05-23 | |||
| WO2010053140A1 | 2010-05-14 |
Foreign References:
| JP2014533302A | 2014-12-11 | |||
| JP2008535921A | 2008-09-04 |
Attorney, Agent or Firm:
MATSUNUMA Yasushi et al. (JP)
Download PDF: